CIK 0001595248
- Non-accelerated filer
- Smaller reporting company
Genprex, Inc.
Sign in to watch- Ticker
- GNPX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- Operating
- EIN
- 900772347
- Phone
- +1 512-537-7997
- Business address
- 3300 BEE CAVE ROAD SUITE 650-227, AUSTIN, TX, 78746
- 4 Grant or award Director acquired 123,795 shares (grant or award)
- 4 Grant or award Director acquired 123,795 shares (grant or award)
- 4 Grant or award Director acquired 123,795 shares (grant or award)
- 4 Open-market buy Chairman, President and CEO bought 19,000 shares at $1.06 ($20,045)
- 4 Open-market buy EVP GC Chief Strategy Officer bought 20,000 shares at $1.07 ($21,478)
- 4 Grant or award EVP GC Chief Strategy Officer acquired 245,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 245,000 shares (grant or award)
- 4 Grant or award Chief Mfgr & Tech Officer acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 245,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 625,000 shares (grant or award)
- 4 Exercise or conversion Chief Financial Officer acquired 116,973 shares (option exercise)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 5 · 99 filings